Yamashita Health Care Holdings (9265) · InitiativeRestated
Promoting the Adoption of an Injectable Drug and Medical Supply Identification System
First written in FY2018. 1 of 2 entries say "Restated". Latest entry: FY2019.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Promoting the Adoption of an Injectable Drug and Medical Supply Identification SystemA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2019RestatedAnnual report
「The company will collaborate with a startup developing an injectable drug and medical materials recognition system that is highly compatible with electronic medical records, and will promote adoption of the system.」
The company reconfirmed the continued initiative to promote adoption of an injectable drug and medical materials recognition system through collaboration with a startup. - FY2018First statedAnnual report
「In May of the current year, the Company acquired an equity interest in a start-up developing an injection drug and medical materials recognition system with a high degree of integration with electronic medical records, and will work with the company to promote the adoption of the system.」
Beginning with the capital participation in May 2018, specific measures to promote system adoption through collaboration with investee companies were presented for the first time.